1
|
Sherman SI: Thyroid carcinoma. Lancet.
361:501–511. 2003. View Article : Google Scholar : PubMed/NCBI
|
2
|
Figge J: Epidemiology of thyroid cancer.
Thyroid Cancer: A Comprehensive Guide to Clinical Management.
Wartofsky L: Humana Press; Totowa, NJ: pp. 77–83. 1999
|
3
|
Gilliland FD, Hunt WC, Morris DM and Key
CR: Prognostic factors for thyroid carcinoma: A population-based
study of 15,698 cases from the Surveillance, Epidemiology and End
Results (SEER) program 1973–1991. Cancer. 79:564–573. 1997.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Chen AY, Jemal A and Ward EM: Increasing
incidence of differentiated thyroid cancer in the United States,
1988–2005. Cancer. 115:3801–3807. 2009. View Article : Google Scholar : PubMed/NCBI
|
5
|
Albores-Saavedra J, Henson DE, Glazer E
and Schwartz AM: Changing patterns in the incidence and survival of
thyroid cancer with follicular phenotype - papillary, follicular,
and anaplastic: a morphological and epidemiological study. Endocr
Pathol. 18:1–7. 2007. View Article : Google Scholar : PubMed/NCBI
|
6
|
Nixon IJ, Whitcher MM, Palmer FL, et al:
The impact of distant metastases at presentation on prognosis in
patients with differentiated carcinoma of the thyroid gland.
Thyroid. 22:884–889. 2012. View Article : Google Scholar : PubMed/NCBI
|
7
|
Mihailovic J, Stefanovic L and Malesevic
M: Differentiated thyroid carcinoma with distant metastases:
probability of survival and its predicting factors. Cancer Biother
Radiopharm. 22:250–255. 2007. View Article : Google Scholar : PubMed/NCBI
|
8
|
Goffredo P, Sosa JA and Roman SA:
Differentiated thyroid cancer presenting with distant metastases: a
population analysis over two decades. World J Surg. 37:1599–1605.
2013. View Article : Google Scholar : PubMed/NCBI
|
9
|
Lin JD, Chao TC, Chou SC and Hsueh C:
Papillary thyroid carcinomas with lung metastases. Thyroid.
14:1091–1096. 2004. View Article : Google Scholar
|
10
|
Pittas AG, Adler M, Fazzari M, Tickoo S,
Rosai J, Larson SM and Robbins RJ: Bone metastases from thyroid
carcinoma: clinical characteristics and prognostic variables in one
hundred forty-six patients. Thyroid. 10:261–268. 2000. View Article : Google Scholar : PubMed/NCBI
|
11
|
Bruglia M, Palmonella G, Silvetti F, et
al: Skin and thigh muscle metastasis from papillary thyroid cancer.
Singapore Med J. 50:e61–e64. 2009.PubMed/NCBI
|
12
|
Luo Q, Luo QY, Sheng SW, et al:
Localization of concomitant metastases to kidney and erector spinae
from papillary thyroid carcinoma using (131)I-SPECT and CT.
Thyroid. 18:663–664. 2008. View Article : Google Scholar : PubMed/NCBI
|
13
|
NCCN guidelines: Thyroid carcinoma.
Version 3. 2011
|
14
|
Tahmasebi FC, Farmer P, Powell SZ, et al:
Brain metastases from papillary thyroid carcinomas. Virchows Arch.
462:473–480. 2013. View Article : Google Scholar : PubMed/NCBI
|
15
|
Liou MJ, Lin JD, Chung MH, Liau CT and
Hsueh C: Renal metastasis from papillary thyroid microcarcinoma.
Acta Otolaryngol. 125:438–442. 2005. View Article : Google Scholar : PubMed/NCBI
|
16
|
Brogioni S, Viacava P, Tomisti L, et al: A
special case of bilateral ovarian metastases in a woman with
papillary carcinoma of the thyroid. Exp Clin Endocrinol Diabetes.
115:397–400. 2007. View Article : Google Scholar : PubMed/NCBI
|
17
|
Rocha Filho FD, Lima GG, Ferreira FV, Lima
MG and Hissa MN: Orbital metastasis as primary clinical
manifestation of thyroid carcinoma - case report and literature
review. Arq Bras Endocrinol Metabol. 52:1497–1500. 2008. View Article : Google Scholar
|
18
|
Argibay Vázquez S, Lancha Hernández C and
Martínez Muñiz A: Metastases in the sphenoidal sinus in a patient
with papillary thyroid cancer. Clin Transl Oncol. 7:324–327. 2005.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Seely S: Possible reasons for high
resistance of muscle to cancer. Med Hypotheses. 6:133–137. 1980.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Bae SY, Lee SK, Koo MY, et al: Distant,
solitary skeletal muscle metastasis in recurrent papillary thyroid
carcinoma. Thyroid. 21:1027–1031. 2011. View Article : Google Scholar : PubMed/NCBI
|
21
|
Dong MJ, Liu ZF, Zhao K, et al: Value of
18F-FDG-PET/PET-CT in differentiated thyroid carcinoma with
radioiodine-negative whole-body scan: a meta-analysis. Nucl Med
Commun. 30:639–650. 2009. View Article : Google Scholar : PubMed/NCBI
|
22
|
Toubert ME, Hindie E, Rampin L, Al-Nahhas
A and Rubello D: Distant metastases of differentiated thyroid
cancer: diagnosis, treatment and outcome. Nucl Med Rev Cent East
Eur. 10:106–109. 2007.
|
23
|
American Thyroid Association (ATA)
Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid
Cancer. Cooper DS, Doherty GM, Haugen BR, et al: Revised American
Thyroid Association management guidelines for patients with thyroid
nodules and differentiated thyroid cancer. Thyroid. 19:1167–1214.
2009. View Article : Google Scholar : PubMed/NCBI
|